A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
Status:
Not yet recruiting
Trial end date:
2023-09-12
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate how much LY3502970 gets into the bloodstream
and how long it takes the body to eliminate when administered orally as tablet and capsule
formulations along with effect of food on LY3502970 in healthy overweight and obese
participants. The study will also evaluate the safety and tolerability of LY3502970 in these
participants. The study is conducted in two parts (part A and B) and will last up to 135 days
including the screening period.